Division of Genetic Medicine and Clinical Pharmacology Archive — Page 7 of 12
-
October 13, 2022
Study to search EHR for undiagnosed genetic diseases
A team at Vanderbilt University Medical Center will explore computational solutions to help address the problem of missed or delayed diagnosis for patients with rare genetic diseases. -
September 13, 2022
VUMC leads effort to map heart disease-causing genetic variations
Researchers from Vanderbilt University Medical Center, Stanford Medicine, the University of Toronto and Brigham and Women’s Hospital in Boston have joined forces to “map” the specific variations in more than 25 key cardiac disease genes that negatively affect heart function. -
August 30, 2022
A new mechanism for lupus
Vanderbilt researchers describe a new mechanism for the most common form of lupus and suggest a new treatment approach to this autoimmune disease. -
August 17, 2022
Researchers discover how salt increases blood pressure
A Vanderbilt research team has discovered that activation of a certain protein complex involved in the inflammatory response in immune cells contributes to salt-sensitive hypertension. -
August 11, 2022
Genotype-specific blood counts
Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts. -
August 3, 2022
Embryo screening for mental illness questioned
Report finds polygenic embryo screening (PES) does not provide an accurate measure of the risk of developing psychiatric disorders later in life. -
July 21, 2022
Longtime division leader earns degree, accolades
Vanderbilt's Amy Shelton, MS, has been awarded a Master of Science Degree in Research Administration with Honors from the Johns Hopkins University Krieger School of Arts and Sciences.